ロード中...
ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost?
It still remains unknown whether angiotensin-receptor blockers (ARBs) are cardioprotective in patients with type 2 diabetes. The recent two clinical trials, the ROADMAP and the ORIENT, have suggested that fatal cardiovascular events or cardiovascular deaths were unexpectedly higher in olmesartan gro...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Libertas Academica
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3699452/ https://ncbi.nlm.nih.gov/pubmed/23885187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCM.S7521 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|